Abstract
Viruses have many strategies for negotiating entry into cells and harnessing the cellular machinery for their propagation [1, 2]. The diversity of strategies is however bound by the central process of translating protein from RNA. The co-evolution of cellular responses to signature viral RNA intermediates and the counter measures employed by viruses, highlight the vulnerability of this aspect of viral replication and the potential of viral RNA as a drug target. In this review we will discuss novel efforts to target the RNA intermediates of the HIV life cycle.
Keywords: RNA Interference, Hairpin Ribozymes, HIV replication, Transdominant Rev Mutant Proteins, Rev Response Element (RRE)
Current Drug Targets
Title: RNA as A Target for Host Defense and Anti-HIV Drugs
Volume: 7 Issue: 12
Author(s): G. C. Fanning
Affiliation:
Keywords: RNA Interference, Hairpin Ribozymes, HIV replication, Transdominant Rev Mutant Proteins, Rev Response Element (RRE)
Abstract: Viruses have many strategies for negotiating entry into cells and harnessing the cellular machinery for their propagation [1, 2]. The diversity of strategies is however bound by the central process of translating protein from RNA. The co-evolution of cellular responses to signature viral RNA intermediates and the counter measures employed by viruses, highlight the vulnerability of this aspect of viral replication and the potential of viral RNA as a drug target. In this review we will discuss novel efforts to target the RNA intermediates of the HIV life cycle.
Export Options
About this article
Cite this article as:
Fanning C. G., RNA as A Target for Host Defense and Anti-HIV Drugs, Current Drug Targets 2006; 7 (12) . https://dx.doi.org/10.2174/138945006779025310
DOI https://dx.doi.org/10.2174/138945006779025310 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Epidermal Growth Factor Receptor and its Trafficking Regulation by Acetylation: Implication in Resistance and Exploring the Newer Therapeutic Avenues in Cancer
Current Topics in Medicinal Chemistry Recent Advances in Targeted Therapy for Glioma
Current Medicinal Chemistry Cannabinoid 1 (CB1) Receptor - Pharmacology, Role in Pain and Recent Developments in Emerging CB1 Agonists
CNS & Neurological Disorders - Drug Targets Managing Comorbidity in COPD: A Difficult Task
Current Drug Targets Mutant Epidermal Growth Factor Receptors as Targets for Cancer Therapy
Current Cancer Drug Targets Meet Our Editorial Board Member
Current Metabolomics Use of Toll-Like Receptor 3 Agonists Against Respiratory Viral Infections
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Synthesis, Characterization and Anti-Listeria monocytogenes Effect of Amino Acid Coated Magnetite Nanoparticles
Current Nanoscience Liposomes as Vehicles for Enhancing Drug Delivery Via Skin Routes
Current Nanoscience Multiple Protective Functions of Sigma1 Receptor
Current Protein & Peptide Science Drug Targeting Strategies for Photodynamic Therapy
Anti-Cancer Agents in Medicinal Chemistry Synthesis of Arylamino-1,3,5-triazines Functionalized with Alkylatin 2-chloroethylamine Fragments and Studies of their Cytotoxicity on the Breast Cancer MCF-7 Cell Line
Anti-Cancer Agents in Medicinal Chemistry Engineered E. coli as Vehicles for Targeted Therapeutics
Current Gene Therapy Urinary Biomarkers for Prostate Cancer
Current Drug Metabolism Targeting the Cancer Initiating Cell: The Ultimate Target for Cancer Therapy
Current Pharmaceutical Design New Approaches to Target the Androgen Receptor and STAT3 for Prostate Cancer Treatments
Mini-Reviews in Medicinal Chemistry Aptamers as Innovative Diagnostic and Therapeutic Agents in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Marine Derived Anticancer Drugs Targeting Microtubule
Recent Patents on Anti-Cancer Drug Discovery Proteomic Analysis of Medicinal Plant <i>Calotropis Gigantea</i> by <i>In Silico</i> Peptide Mass Fingerprinting
Current Computer-Aided Drug Design Recent Progress on Fucosyltransferase Inhibitors
Mini-Reviews in Medicinal Chemistry